| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,904 |
4,970 |
$269K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,599 |
2,021 |
$68K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
198 |
164 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
411 |
301 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
245 |
221 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
402 |
297 |
$4K |
| 99307 |
|
1,503 |
1,330 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,470 |
925 |
$3K |
| 81002 |
|
409 |
320 |
$700.64 |
| 90686 |
|
80 |
66 |
$647.21 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
78 |
66 |
$445.26 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
202 |
140 |
$265.45 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
527 |
377 |
$257.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
12 |
$147.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
56 |
40 |
$125.49 |
| 3075F |
|
1,248 |
878 |
$20.00 |
| 3074F |
|
2,644 |
1,757 |
$15.00 |
| 94760 |
|
74 |
46 |
$13.17 |
| 3077F |
|
1,727 |
1,154 |
$5.00 |
| 3078F |
|
2,419 |
1,659 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
3,798 |
2,159 |
$0.00 |
| 1159F |
|
8,392 |
5,582 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
732 |
546 |
$0.00 |
| 1160F |
|
8,313 |
5,540 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
554 |
449 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
14 |
14 |
$0.00 |
| G8422 |
Bmi not documented, documentation the patient is not eligible for bmi calculation |
2,749 |
2,152 |
$0.00 |
| 1126F |
|
4,515 |
3,179 |
$0.00 |
| 1125F |
|
3,651 |
2,572 |
$0.00 |
| 3080F |
|
1,150 |
804 |
$0.00 |
| 3079F |
|
1,908 |
1,339 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,138 |
849 |
$0.00 |
| 1170F |
|
9,819 |
6,245 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,086 |
596 |
$0.00 |